Changed endpoints cannot save Proteon from becoming a shell - Vantage

Changed endpoints cannot save Proteon from becoming a shell  Vantage

The tried and tested biotech strategy of finding a new endpoint to follow after a clinical trial failure has not worked for Proteon Therapeutics. The group's lead ...